Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-008888
Filing Date
2025-01-24
Accepted
2025-01-24 17:13:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3680
  Complete submission text file 0000950170-25-008888.txt   5109
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36687 | Film No.: 25555109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
MORTIMER IAN (Reporting) CIK: 0001619961 (see all company filings)

Type: 144